ABOUT US
Making a Difference
Approximately 5 out of every 1000 newborn infants will have some degree of brain injury. CergenX was formed by a group of scientists and software engineers with the aim of using recent advances in AI to help identify infants most at risk. Early detection is essential for early interventions and improved outcomes.
CergenX is a spin-out from the INFANT Research Centre at University College Cork.
OUR EXEC TEAM
CSO & Founder
PROF GERALDINE BOYLAN
Geraldine is the Co-Founder and Chief Scientific Advisor of CergenX. She has over 25 years of experience in human physiological signal measurement and analysis, particularly neonatal electroencephalography and has published hundreds of peer-reviewed journal papers and book chapters on this subject. She is the Founder and Director of the INFANT Centre for Maternal and Child Health Research at University College Cork (infantcentre.ie), and Professor of Neonatal Physiology.
RECENT NEWS
July 2023
July 2023
CergenX secures extra €1.2m for AI-based baby brain scanning software - Business Post
July 2023
CergenX raises €1.2m in funding to develop newborn brain screening - Irish Times
August 2022
Better brain health for all babies made possible with AI - Silicon Republic
July 2022
CergenX raises €800k for newborn brain screening technology - Business Post
June 2022
Cork-based start-up CergenX planning AI-powered brain screening for newborn babies - Irish Times